MRE11 expression was not associated with any clinicopathologic characteristics, but there appeared to be better progression-free survival in MRE11-negative patients compared to MRE11-positive patients treated with oxaliplatin, although the results failed to reach statistical significance.
← all excerpts
MRN (MRE11-RAD50-NBS1) Complex in Human Cancer and Prognostic Implications in Colorectal Cancer.
1
—
—